Articles tagged with Drug Interactions
A study found that 45% of heart patients use complementary or alternative medicines, but only 39% believe their doctors should know. Physicians must educate patients on risks and provide safe alternatives to prevent life-threatening interactions with prescribed cardiac medications.
E-MAP technique enables researchers to analyze epistatic interactions between genes in a systematic way, revealing new insights into protein functions and evolutionary processes. By quantifying the effects of interacting mutant genes, E-MAPs help optimize drug treatments and improve our understanding of biological systems.
Researchers developed a new method to identify novel drug targets for fighting malaria by comparing protein interactions in Plasmodium falciparum with other organisms. This approach could lead to the development of antimalarial drugs that exploit unique differences in protein wiring.
A study found that medical students are frequently exposed to pharmaceutical company gifts and activities, with 93.2% of respondents required to attend at least one sponsored lunch. Many students also believe they are entitled to gifts and think sponsored grand rounds can be educational but biased.
The study highlights that current clinical practice guidelines (CPGs) often fail to address the complexities of caring for older adults with multiple chronic diseases. The authors recommend that CPGs be revised to include information on comorbidity, patient preferences, and life expectancy to provide more tailored guidance for clinicians.
Standard clinical practice guidelines often focus on one disease and exclude coexisting conditions, leaving clinicians without guidance for caring for older patients with multiple chronic diseases. This can lead to polypharmacy, medication errors, and an unsustainable treatment burden.
The Lancet emphasizes the need for open discussion to understand the true extent of drug use, its risks, and effective management strategies. Doctors are lacking essential knowledge due to a lack of transparency and open debate.
Researchers believe gut microbes influence how medicines affect the body, leading to individualized treatments and drug discovery. Changes in gut microbiome composition may impact medication effectiveness between individuals.
A Vanderbilt University Medical Center study has identified a crucial early step in the HIV assembly process, revealing how the Gag protein is directed to the multivesicular body. The discovery could lead to the development of new drugs targeting this step, potentially blocking viral replication.
A small study found that St. John's wort amplifies the effect of blood thinner Plavix, potentially increasing the risk of bleeding among those who take both. The researchers plan to conduct further studies to confirm the finding and explore its implications for new drug development.
A recent UCLA study published in the American Journal of Public Health found that people's drinking habits decrease with age, with an average decline of 9-11% per decade. The study used data from the National Health and Nutrition Examination Survey to track changes in drinking behavior over time.
A Princeton University study shows that galanin triggers desires for fatty foods and alcohol, perpetuating a cycle of positive feedback. The finding suggests the possibility of creating a drug to block galanin in fighting alcoholism.
Scientists at UNC have discovered a basic mechanism in cell growth control involving damaged DNA, pointing to a potential target for drug development. The study found that the cellular enzyme family Cullin4 plays a crucial role in preventing replication of damaged genomic material.
Researchers describe how microbes in the gut form the second largest metabolic 'organ' in the body, influencing disease processes alongside genetic and environmental factors. The discovery of this 'superorganism' could lead to new approaches to treating disease and developing personalized medicine.
Researchers discovered that the HMW1B protein forms a tetramer structure, unlike previously thought monomers, which creates an active pore for substance movement across cell membranes. This finding may lead to new targets for drugs to treat H. influenzae infection.
A review found no reliable scientific evidence supports the use of C. aurantium for weight loss, and high doses may not be safe. The herb interacts with drugs in a manner similar to grapefruit juice, increasing blood levels and potential side effects.
Research studies on citrus fruits have discovered compounds that fight cancer, obesity, and cholesterol. Compounds in grapefruit may yield a "super-pill" to reduce cost of prescription drugs.
Scientists have developed a technique to detect protein interactions using firefly luciferase. The method was tested on human proteins interacting with the antibiotic rapamycin and showed accuracy and selectivity. The technique also demonstrated its potential in studying other protein pairs linked to cell life cycle regulation.
Researchers investigated acamprosate's interactions with alcohol in a six-week study. The findings suggest that acamprosate does not alter the rate of absorption or elimination of alcohol by the body, disrupting effects on performance tasks, or most mood effects. This suggests potential as a medication for treating alcoholism.
Researchers identified Mpdz gene as key player in physical dependence and withdrawal from sedative-hypnotic drugs. The study found that higher expression of Mpdz correlated with reduced susceptibility to drug withdrawal seizures.
A study by Yale University researchers found that patients with knee arthritis prefer safer treatment options despite potential reduced efficacy. Older patients rarely opt for anti-inflammatory drugs, indicating the importance of considering individual preferences in treatment decisions.
The IU School of Medicine aims to integrate competency-based curriculum with the 'hidden curriculum' to improve practice and professionalism. The school's unique approach involves changing its culture to mirror the social context of care, teaching students about relationships and customer experience.
A study found that only 25% of internal medicine residency programs in the US have formal instruction on interacting with drug company sales representatives. A six-hour curriculum was developed to teach residents about the ethics of these interactions and how they can be influenced by marketing tactics.
SOS Rx aims to produce behavior changes in consumers through education efforts and institutional changes within the health care system through advocacy. The coalition is exploring ways to promote system-wide changes, including a clearinghouse of safe practices and personal medication records.
A study by the University of Pittsburgh Medical Center found that most interactions between prescription medications and dietary supplements are not serious, affecting approximately 94% of patient population. Healthcare providers should continue to inquire about supplement use to consider potential interactions.
Researchers found that alcohol enhances the rewarding effects of nicotine, leading to increased smoking rates. A potential new treatment involves using mecamylamine to counteract both nicotine and alcohol's effects, helping smokers quit both substances.
A UMHS study found that heavy drinkers with chronic back pain showed less physical disability than light drinkers on functional tests. Women were underreported for heavy drinking, suggesting doctors should be more vigilant about prescribing narcotic pain relievers.
Epilepsy can develop as people age, often due to common health problems like stroke, cancers, or heart diseases. The NCOA and Epilepsy Foundation launch an initiative to educate about epilepsy in the elderly, emphasizing subtle symptoms and effective treatment options.
A national expert panel updated widely used criteria for potentially harmful medications in older adults. The 1997 Beers Criteria has identified 48 medications to avoid, including estrogen and Benadryl, due to increased risk of adverse drug events such as depression and bleeding.
A new study found that ximelegatran, a novel oral thrombin inhibitor, is as effective as Coumadin in preventing strokes in people with atrial fibrillation but without the need for regular blood tests or dose adjustments. The drug has been shown to reduce major bleeding incidents and may be approved by the FDA within the next year.
Researchers have identified a key molecular signaling system controlling the development of smooth muscle in embryos, which may lead to new treatments for heart disease, cancer, and neurological disorders. The 'Jelly Belly' gene plays a crucial role in signaling primitive cells to become muscle cells.
A new study by University of Pennsylvania researchers found that mandatory prescription drug utilization reviews have no detectable effect on prescribing errors or patient outcomes. The program's reliance on computer alerts and guidelines was deemed ineffective in changing physician behavior.
Pharmacokinetic data suggest that 908 can be co-administered with Maalox TC or Zantac without dose adjustments. Co-administration with Lipitor increased ATO exposure but did not affect 908 PK.
A new study suggests that patients with heart failure may only need one medication to target both beta-adrenergic and angiotensin receptors, rather than multiple blockers. This finding could lead to tailored treatment strategies for individual patients, reducing the risk of side effects.
Researchers at University at Buffalo's Laboratory for Antiviral Research are conducting a comprehensive study to measure concentrations of drugs and analyze their pharmacogenetic basis. The goal is to understand the net effect of antiretroviral drugs on other pharmaceuticals taken by HIV patients.
A study found that osteopathic physicians were more likely to use patients' first names, explain medical conditions, and discuss social and emotional impacts of illnesses. Osteopaths also asked patients more questions about their concerns, while allopaths focused on the scientific basis of treatment.
Health food store employees frequently advise customers on unproven products for breast cancer treatment, raising concerns about patient safety. The high cost of these products, up to $600 per month, is also a significant burden on vulnerable patients.
A new theory suggests that human metabolism operates like a pinball machine, influencing drug toxicity and disease development. The researchers used metabonomics to study global human metabolism and its interactions with drugs, environment, and gut microflora.
Combining herbal supplements with regular medication without consulting a doctor can lead to adverse interactions. Patients should discuss their herbal supplement use with their primary physician to ensure safe treatment and prevent unexpected complications.
The updated Guidelines provide practitioners with a list of suggested combination regimens for the initiation of antiretroviral therapy, taking into consideration factors such as potency, toxicities, and dosing frequency. The revised document aims to simplify the process of selecting an effective treatment regimen for HIV/AIDS patients.
A recent survey found that nearly half of primary care physicians feel uncertain in diagnosing adult ADHD, highlighting the need for better training and symptom assessment tools. The survey also revealed that only 34% of physicians report being knowledgeable about adult ADHD, compared to 92% for depression.
A study by Columbia University and the University of Washington found that pharmaceutical sales reps have modest to very small influence on prescribing behavior. In contrast, distributing drug samples plays a more positive role in contrasting medications and helping manufacturers maintain market share.
A study found that most physical activity web sites provide general knowledge but lack personalized assistance to users. Tailored messages can increase the chance of material usage and personal change. One site, JustMove.org, outperformed others in providing interaction and tailored assistance.
A new study examines the metabolic and cardiovascular effects of consuming caffeine with naringin, a flavonoid found in grapefruit. The results show that caffeine significantly increases resting metabolic rate, but adding naringin does not further enhance energy expenditure or affect blood levels of caffeine.
Researchers have found that simvastatin, a cholesterol-lowering medication, reduces the number and volume of active MS lesions. The study suggests statins may have therapeutic value in treating multiple sclerosis, but further studies are needed to confirm its effectiveness.
The new guidelines recommend directly observed therapy for patients with TB to improve treatment completion rates. Four regimens are recommended for treating patients with drug-susceptible organisms, with an initial phase of 2 months followed by a continuation period of 4 to 7 months.
The survey found that 35% of respondents discussed a health concern with their doctor after seeing an advertised drug. Patients who received a new diagnosis were more likely to have high-priority conditions such as arthritis or diabetes. Additionally, physicians suggested lifestyle changes and quit-smoking advice in over half of visits.
Researchers at Johns Hopkins have determined the 3D structure of the HER2 breast cancer receptor, shedding light on its interactions with the Herceptin antibody. The findings could lead to the design of more effective drugs for treating breast cancer.
Researchers investigate how pregnancy affects medication levels in the blood, suggesting that placenta's organic cation transporter plays a crucial role. The study aims to inform safe dosing practices for pregnant women taking common medications, potentially improving treatment outcomes and reducing risks.
Researchers have discovered a new way to prevent cell death in the brain, which could lead to treatments for stroke, schizophrenia, and other neurological disorders. By enhancing the interaction between two proteins, they may be able to design medications that target specific brain functions.
Researchers highlight the importance of selecting an antiemetic with low potential for drug interactions in elderly cancer patients. Granisetron, a 5HT3 receptor antagonist, is considered a safe choice due to its low risk of cardiovascular toxicity and adverse interactions.
Researchers found that transplant outcomes for HIV patients are similar to those without HIV, but managing anti-rejection drugs and HAART therapy poses a challenge due to potential drug interactions. Studies showed that HIV viral loads remain undetectable in most patients after transplantation.
A new virtual clinic, developed by Dartmouth Medical School, aims to improve understanding of genetic testing and services among non-geneticists. The program uses interactive multimedia and expert simulations to train healthcare providers on genetics in clinical practice, working with labs and genetic counselors.
Researchers at Texas A&M University have created a haptic device called 'Touché' that allows chemists to feel the interaction between molecules, enabling more accurate drug design. The device enables simulation of large numbers of atom interactions in a short period, improving pharmacological research.
The U-M Depression Center will expand outreach activities, automate treatment reporting, and coordinate care through trained specialists to improve depression treatment. The gift also enables the development of strategies for improving treatment adherence, a key factor in successful treatment outcomes.
The Society for Women's Health Research is launching a new series on women and pharmacology, covering topics such as sex differences in drug metabolism and the risks of polypharmacy. The seven articles will provide valuable information to the public on how drugs affect women and inform efforts to improve women's health.
A study found that patients who had one-on-one discussions with pharmacists reported using less medication and having fewer medication-related problems. The sessions helped increase communication between patients and their physicians, leading to improved health outcomes.
Researchers have found that nornicotine, a breakdown product of nicotine, can catalyze certain chemical reactions in the body, potentially triggering adverse health effects. This interaction may also lead to reduced drug potency and increased risk of side effects for those taking medications while smoking or using nicotine products.
A study of 145 heart patients found that 74% used complementary and alternative medicine (CAM) therapy, with 60% using supplements or mind-body techniques. Many patients took prescription medications and CAM substances together, posing a risk of bleeding problems, including gastrointestinal bleeding or surgical complications.
A new HIV treatment potential has been discovered through protein discovery by Rutgers cell biologist, Dr. Firestein. The identified protein, HP68, plays a crucial role in the assembly of HIV capsids, and disrupting its interaction with Gag proteins may stop HIV production.